Intermittent Treatment With Sulfadoxine-pyrimethamine for Malaria Control in Infants
Status:
Completed
Trial end date:
2005-09-01
Target enrollment:
Participant gender:
Summary
The purpose of this study is to assess the effectiveness of Intermittent Preventive Treatment
in Infants (IPTi) with Sulfadoxine-Pyrimethamine to reduce the numbers of malaria attacks,
episodes of anemia, and the overall morbidity and mortality
Phase:
Phase 4
Details
Lead Sponsor:
Bernhard Nocht Institute for Tropical Medicine
Collaborators:
Deutscher Akademischer Austausch Dienst German Federal Ministry of Education and Research The Volkswagen Foundation
Treatments:
Fanasil, pyrimethamine drug combination Pyrimethamine Sulfadoxine